Having confirmed that BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive CSC-like cellular states, we preliminary evaluated whether RANKL/RANK signaling could also favor the maintenance of CSC populations in genetically diverse subtypes of breast carcinoma cells. This evidence concerns the gene BRCA1 and breast carcinoma.